Vaccine Therapy in Treating Patients With HER2-Negative Stage III-IV Breast Cancer

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified June 2014 by University of Washington
Sponsor:
Collaborator:
Information provided by (Responsible Party):
University of Washington
ClinicalTrials.gov Identifier:
NCT02157051
First received: June 3, 2014
Last updated: June 4, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2016 (Final data collection date for primary outcome measure)